The results from Apple, Mastercard and Gilead Sciences report
An investor could have gotten a whiplash and tried to keep track of all quarterly results revealed by companies today. There was no relief after hours as more than a few reports from large companies came in through the transom.
<p class = "canvas atom canvas-text Mb (1[ads1].0em) Mb (0) – sm Mt (0.8 em) – sm" type = "text" content = "This is one of these nights when we can't cover all the major companies that report, however, we can take on three of the biggest stocks that do. spirit, here's the latest from Apple (NASDAQ: AAPL) Mastercard [19659002] (NYSE: MA) and Gilead Sciences (NASDAQ: GILD) . " data-reactid = "12"> This is one of those nights where we can't cover every major reporting company. However, we can take on three of the biggest stocks that do. In that spirit, here is the latest from Apple (NASDAQ: AAPL) Mastercard (NYSE: MA) and Gilead Sciences (NASDAQ: GILD) .
Apple Q3 turns on revenue and EPS
Of the three stocks in this digestion, investors tonight are most excited about Apple. They have offered the company's shares by 4% so far in the afternoon trade.
This is after the release of the company's third quarter. For the quarter, it posted net sales of $ 53.8 billion, up 1% year-on-year. A marginal decline in revenue from products was offset by services, which rose by 13% to nearly $ 11.5 billion. On average, analysts had expected a total revenue of $ 53.3 billion.
<p class = "canvas atom canvas text Mb (1.0 cm) Mb (0) – sm Mt (0.8 cm) – sm" type = "text" content = "Initially, accepted accounting principles were ( GAAP ) revenues of just over $ 10 billion, or $ 2.18 per share, although this represented a 13% year-over-year decline, topping $ 2.09 earnings per share the forecasters modeled. "data-reactid =" 16 "> Initially, Approved Accounting Principles (GAAP) revenues were just over $ 10 billion, or $ 2.18 per share. While this represented a 13% year-on-year decline, it topped $ 2.09 earnings per share as forecasters modeled.
Apple investors are probably delighted by the fact that service revenue is a bright rising place for the company. In addition, hardware sales are not eroding as much as anyone feared (due in no small part to smartphone saturation) – the company's leading product is still the iPhone.
Apple provided guidance for its current Q4. The company believes it will generate revenues of between $ 61 and $ 64 billion, with operating expenses ranging from $ 8.7 billion to $ 8.8 billion. It did not provide an estimate of net profit.
Mastercard app icon.
Image source: Mastercard.
Mastercard QPS top analyst EPS estimate
Mastercard also delivered its latest set of numbers after the closing bell. The company said Q2 of fiscal 2019 net revenue was $ 4.1 billion, up 12% from the $ 3.7 billion it raised in the same quarter of 2018. Net gains (non-GAAP) (adjusted) at $ 1.9 billion ($ 1.89 per share) for an 11% improvement.
The top line figure was mainly in line with analysts' estimates. However, earnings per share topped the average analyst estimate of $ 1.83.
<p class = "canvas atom canvas text Mb (1.0 cm) Mb (0) – sm Mt (0.8 cm) – sm" type = "text" content = "Mastercard attributed the growth to general global expansion and to recent acquisitions, it continues to keep the shopping bag open – in March it signed an agreement to buy cross-border money transfer specialist Transfast. Mastercard has also recently entered into several new and expanded partnerships . "34"> Mastercard attributed the growth to general global expansion and to recent acquisitions. It continues to keep the shopping bag open – in March it signed an agreement to buy specialist Transfast across borders. Mastercard has also recently entered into several new and expanded partnerships.
Continued growth is expected for all major credit card companies, due to the ever-snowing global migration away from cash and toward plastic and digital commerce. Mastercard has significant global reach, and as such can grow organically in "under-carded" regions.
At present, the Mastercard share is basically flat in aftermarket action.
Gilead Sciences & # 39; Q2 tie, but beats convincingly
Like Apple, Gilead Sciences hit both the top and bottom line for the last reported quarter.
Said quarter, second quarter of fiscal year 2019, saw the large pharmaceutical company earn $ 5.69 billion, up from $ 5.65 billion in the same period the year before. Adjusted net income was $ 2.3 billion, or $ 1.82, which was lower than $ 2.5 million ($ 1.91) in Q2 2018.
Nevertheless, the two headline figures exceeded analysts' expectations. These were for $ 5.53 billion in sales and $ 1.72 for net profits per share.
The company said that its HIV treatments, especially Biktarvy, sold well during the quarter. These and other factors motivated Gilead to increase revenue guidance for the entire 2019. For the year, the company expects product sales to hit $ 21.3 billion to $ 21.8 billion, up from the previous range of $ 21.6 billion to $ 22.1 billion dollars.
<p class = "canvas atom canvas text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "On the other hand, on the back of it recently announced its collaboration with Galapagos NV Gilead set a significant GAAP EPS estimate, now $ 1.40 to $ 1.50 for the year, from its previous assumption of $ 3.90 to $ 4.00. "Data-reactid =" 46 "> On the other hand, on the back of the recently announced collaboration with Galapagos NV Gilead significantly reduced the GAAP EPS estimate. This now stands at $ 1.40 to $ 1.50 for the year, from the previous assumption of $ 3.90 to $ 4.00.
Post-traders do not seem to be touched by these figures. Gilead's stock price is just really up tonight.
<p class = "canvas atom canvas text Mb (1.0 em) Mb (0) – sm Mt (0.8 em) – sm" type = "text" content = " More From The Motley Fool "data-reactid =" 48 "> More From The Motley Fool
<p class =" canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt ( 0.8em) – sm "type =" text "content =" Eric Volkman has no position in any of the listed shares. The Motley Fool owns shares in and recommends Apple, Gilead Sciences and Mastercard. Motley Fool has the following options: short January 2020 $ 155 calls on Apple, long January 2020 $ 150 calls on Apple, short January 2020 $ 155 calls on Apple, and long January 2020 $ 150 calls on Apple Motley Fool has a disclosure policy "data-reactid =" 56 "> Eric Volkman has no position in any of the aforementioned stocks. The Motley Fool owns shares in and recommends Apple, Gilead Sciences and Mastercard. Motley Fool has the following options: short January 2020 $ 155 calls on Apple, long January 2020 $ 150 calls on Apple, short January 2020 $ 155 calls on Apple, and long January 2020 $ 150 calls on Apple. The Motley Fool has a disclosure policy.
